CBX2 and cancer: Among 29 upregulated genes, high expression of CBX2, GNG4, PHLDA1, RNF43 and STC2 associated with poor DFI of cancer patients; high expression of CBX2, SULT2B1 and STC2 associated with poor PFI; high expression of STC2 associated with poor DSS; while high expression of MMP1 associated with good DFI; high expression of CDK1 and TMEM97 associated with good PFI; high expression of NFE2L3 associated with good DSS.